In bioprocessing, many experts talk about the advantages of single-use technology, but making it work requires access to the necessary tools—and lots of them. That’s what MilliporeSigma decided to ...
The pharmaceutical and biopharmaceutical industry needs to execute a shift from large-volume, single-product processes to small-volume, multiproduct processes. The shift is not restricted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback